GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
Rating: AMED
Outperform

Amedisys Inc (NASDAQ: AMED) rated to Outperform by Wells Fargo

Tuesday,  Sep 1, 2015  10:25 AM ET by Lynn Gilbert

Wells Fargo rated
Amedisys Inc (NASDAQ: AMED) to Outperform.

Amedisys, Inc. (Amedisys) is a provider of home health services to the chronic, co-morbid, aging American population. The services that the Company provides include both home health and hospice services with approximately 87% of its revenue derived from Medicare. As of December 31, 2008, Amedisys owned and operated 480 Medicare-certified home health agencies, 48 Medicare-certified hospice agencies and managed the operations of four Medicare-certified home health and two Medicare-certified hospice agencies in 37 states within the United States, the District of Columbia and Puerto Rico. Its home health patient is Medicare eligible, approximately years old and takes approximately 12 different medications on a daily basis and has multiple co-morbidities. For the Company?s home health patients, it receives a 60-day, episodic-based payment from Medicare. On March 26, 2008, the Company completed the acquisition of TLC Health Care Services, Inc.

The investment research content is provided by Wells Capital Management, a registered investment adviser and wholly owned subsidiary of Wells Fargo Bank, N.A. Our economists’ expertise on domestic markets, and national and global trends, is an important resource to the firm. Wells Capital Management economists are known for their thoughts on investment strategy, macro-economic forecasts and other top-down analysis, and share their views on bonds, midcaps and liquidity management in their publications.



RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy